The Patent Finder

Terms ending in 2029

Precision Biosciences, Inc.

Every in-force patent on Precision Biosciences, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,338,157Rationally-Designed Meganuclease Variants of LIG-34 and I-Crei for Maize Genome Engineering
In force
 · Medium confidence
Precision Biosciences, Inc.In forceMedium confidence
US 9,683,257Recognition Sequences for I-Crei-Derived Meganucleases and Uses Thereof
In force
 · Medium confidence
Precision Biosciences, Inc.In forceMedium confidence
US 10,273,524Recognition Sequences for I-Crei-Derived Meganucleases and Uses Thereof
In force
 · Low confidence
Precision Biosciences, Inc.In forceLow confidence
US 10,287,626Recognition Sequences for I-Crei-Derived Meganucleases and Uses Thereof
In force
 · Low confidence
Precision Biosciences, Inc.In forceLow confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited